209 assets in Breast Carcinoma

Therapeutic assets addressing Breast Carcinoma, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Pegfilgrastim Breast Carcinoma	Centre Georges Francois Leclerc	P1/2	CCC (54)
Utomilumab Breast Carcinoma	Laura Huppert, MD, BA	P2	CCC (54)
Acolbifene Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Amiloride Breast Carcinoma	Laura Huppert, MD, BA	P2	CCC (53)
Binimetinib Breast Carcinoma	Laura Huppert, MD, BA	P2	CCC (53)
Caffeine Breast Carcinoma	NYU Langone Health	P2	CCC (53)
Crizotinib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Defactinib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Degarelix Breast Carcinoma	Jose Pablo Leone	P2	CCC (53)
ds-8201a Breast Carcinoma	MedSIR	P2	CCC (53)
Fexagratinib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Fezolinetant Breast Carcinoma	University of Michigan Rogel Cancer Center	P2	CCC (53)
Gm-Csf Breast Carcinoma	Second Affiliated Hospital of Soochow University	P2	CCC (53)
Gsk-2636771 Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Hrs-1167 Breast Carcinoma	Fudan University	P2	CCC (53)
Immunoglobulin G1-Kappa, Anti-[Homo Sapiens Erbb2 (Receptor Tyrosine-Protein Kinase Erbb-2, Epidermal Growth Factor Receptor 2, Egfr2, Her2, Her-2, P185C-Erbb2, Neu, Cd340)], Humanized Monoclonal Antibody; Conjugated To Auristatin E Breast Carcinoma	Shanghai Miracogen Inc.	P2	CCC (53)
Immunoglobulin G4, Anti-(Human Programmed Cell Death Protein 1) (Human Monoclonal Regn2810 Heavy Chain), Disulfide With Human Monoclonal Regn2810 .Kappa.-Chain, Dimer Breast Carcinoma	City of Hope Medical Center	P2	CCC (53)
Ipatasertib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Ivuxolimab Breast Carcinoma	Laura Huppert, MD, BA	P2	CCC (53)
Larotrectinib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Memantine Breast Carcinoma	UNC Lineberger Comprehensive Cancer Center	P2	CCC (53)
Osimertinib Breast Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Oxodotreotide Breast Carcinoma	OHSU Knight Cancer Institute	P2	CCC (53)
Pan-Fgfr Tyrosine Kinase Inhibitor Jnj-42756493 Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Pelareorep Breast Carcinoma	Mridula George, MD	P2	CCC (53)
Relatlimab Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Retifanlimab Breast Carcinoma	Mridula George, MD	P2	CCC (53)
Sapanisertib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Shr-A1811 For Breast Carcinoma	Henan Cancer Hospital	P2	CCC (53)
Sodium Alginate Breast Carcinoma	Taipei City Hospital	P2	CCC (53)
Starch Breast Carcinoma	University of Michigan Rogel Cancer Center	P2	CCC (53)
Tart Cherry Breast Carcinoma	University of California, Davis	P2	CCC (53)
Tuvonralimab Breast Carcinoma	RenJi Hospital	P2	CCC (53)
Ulixertinib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Wokvac Vaccine Breast Carcinoma	H. Lee Moffitt Cancer Center and Research Institute	P2	CCC (53)
Young Til Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (53)
Adavosertib Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (52)
TIL Breast Carcinoma	Essen Biotech	P1/2	CCC (50)
Avelumab Breast Carcinoma	Laura Huppert, MD, BA	P2	CCC (48)
bnt323 Breast Carcinoma	BioNTech SE	P1/2	CCC (48)
bnt327 Breast Carcinoma	BioNTech SE	P1/2	CCC (48)
Entrectinib Breast Carcinoma	OHSU Knight Cancer Institute	P1	CCC (48)
Monosialotetrahexosylganglioside Breast Carcinoma	Alliance for Clinical Trials in Oncology	P2	CCC (48)
Omega-3-Acid Ethyl Esters Breast Carcinoma	National Cancer Institute (NCI)	P2	CCC (48)
Patritumab Deruxtecan Breast Carcinoma	Gustave Roussy, Cancer Campus, Grand Paris	P1/2	CCC (48)
Polo-Like Kinase 1 Inhibitor Nms-1286937 Breast Carcinoma	Antonio Giordano, MD	P1/2	CCC (48)
Vemurafenib Breast Carcinoma	OHSU Knight Cancer Institute	P1	CCC (48)
Zunsemetinib Breast Carcinoma	Washington University School of Medicine	P1/2	CCC (48)
[14C]AZD9833 Breast Carcinoma	AstraZeneca	P1	CC (47)
177lu-dfc413 Breast Carcinoma	Novartis Pharmaceuticals	P1	CC (43)

Showing 101 to 150 of 209 assets

PreviousPage 3 of 5Next